Cargando…
Plasma-Methylated SEPT9 for the Noninvasive Diagnosis of Gastric Cancer
Background. Gastric cancer (GC) is one of the most prevalent cancers globally. This study was designed to evaluate the potential performance of plasma SEPT9 methylation (mSEPT9) as a noninvasive biomarker for the diagnosis of GC. Methods. A total of 182 participants, i.e., 60 patients with GC, 39 wi...
Autores principales: | Zhao, Luyao, Li, Muran, Zhang, Shiwu, Liu, Yandi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9656015/ https://www.ncbi.nlm.nih.gov/pubmed/36362627 http://dx.doi.org/10.3390/jcm11216399 |
Ejemplares similares
-
Plasma Methylated RNF180 for Noninvasive Diagnosis of Gastric Cancer
por: Zhao, Luyao, et al.
Publicado: (2022) -
Cell-Free Circulating Methylated SEPT9 for Noninvasive Diagnosis and Monitoring of Colorectal Cancer
por: Fu, Bo, et al.
Publicado: (2018) -
SEPT9 Gene Methylation as a Noninvasive Marker for Hepatocellular Carcinoma
por: Li, Baoliang, et al.
Publicado: (2020) -
The role of (m)SEPT9 in screening, diagnosis, and recurrence monitoring of colorectal cancer
por: Sun, Jie, et al.
Publicado: (2019) -
SNHG3 Affects Gastric Cancer Development by Regulating SEPT9 Methylation
por: Li, Wei, et al.
Publicado: (2022)